Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation

BACKGROUND: We aimed to examine the comparative effectiveness and safety between low-dose dabigatran and rivaroxaban in atrial fibrillation (AF) patients. METHODS: Using the National Health Insurance claims database in Taiwan, we conducted head-to-head comparisons among adult non-valvular AF patient...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Acta Cardiol Sin
Main Authors: Meng, Shih-Wei, Lin, Ting-Tse, Liao, Min-Tsun, Chen, Ho-Min, Lai, Chao-Lun
Formato: Artigo
Idioma:Inglês
Publicado: Taiwan Society of Cardiology 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6342833/
https://ncbi.nlm.nih.gov/pubmed/30713399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS.201901_35(1).20180817A
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares